BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 13491414)

  • 1. 5-Hydroxytryptamine antagonism by lysergic acid diethylamide after intracerebral injection in conscious mice.
    HALEY TJ
    J Am Pharm Assoc Am Pharm Assoc; 1957 Jul; 46(7):428-30. PubMed ID: 13491414
    [No Abstract]   [Full Text] [Related]  

  • 2. The antagonism between 5-hydroxytryptamine and certain derivatives of lysergic acid.
    SAVINI EC
    Br J Pharmacol Chemother; 1956 Sep; 11(3):313-7. PubMed ID: 13364207
    [No Abstract]   [Full Text] [Related]  

  • 3. Lysergic acid diethylamide antagonism of certain drugs.
    BROWN BB
    Ann N Y Acad Sci; 1957 Mar; 66(3):677-85. PubMed ID: 13425250
    [No Abstract]   [Full Text] [Related]  

  • 4. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysergic acid diethylamide: role in conversion of plasma tryptophan to brain serotonin (5-hydroxytryptamine).
    Lin RC; Ngai SH; Costa E
    Science; 1969 Oct; 166(3902):237-9. PubMed ID: 5809595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of lysergic acid diethylamide, 5-hydroxytryptamine, and related compounds on the liver fluke, Fasciola hepatica.
    MANSOUR TE
    Br J Pharmacol Chemother; 1957 Dec; 12(4):406-9. PubMed ID: 13489165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism between lysergic acid diethylamide and 5-hydroxytryptamine.
    GADDUM JH
    J Physiol; 1953 Jul; 121(1):15P. PubMed ID: 13085323
    [No Abstract]   [Full Text] [Related]  

  • 8. [Considerations on the mechanism of action of lysergic acid diethylamine].
    BARBOLINI G; TONINI G
    Boll Soc Ital Biol Sper; 1956; 32(1-2):25-6. PubMed ID: 13374001
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine.
    Winter JC
    J Pharmacol Exp Ther; 1978 Feb; 204(2):416-23. PubMed ID: 621672
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of 5-hydroxytryptamine and d-lysergic acid diethylamide in the transcallosal response.
    Bond HW; Guth PS
    Life Sci; 1968 Mar; 7(5):249-58. PubMed ID: 5641717
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of cyproheptadine and of D-lysergamide on the rise in temperature induced by intracerebroventricular 5-hydroxytryptamine, noradrenaline and dopamine in conscious rabbits.
    Jacob JJ; Girault JM
    Eur J Pharmacol; 1974 Jun; 27(1):59-67. PubMed ID: 4854891
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of D-lysergic acid diethylamide (LSD-25) and 2-bromo-D-lysergic acid diethylamide (BOL-148) on sleeping behavior in rats].
    Loew DM; Depoortere H; Vigouret JM
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):394-5. PubMed ID: 4326420
    [No Abstract]   [Full Text] [Related]  

  • 13. Some in vitro effects of chlorpromazine, lysergic acid diethylamide, and 5-hydroxytryptamine on the respiration of rat brain.
    STARBUCK WC; HEIM HC
    J Am Pharm Assoc Am Pharm Assoc; 1959 Apr; 48(4):251-3. PubMed ID: 13641067
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of intraventricular injection of d-lysergic acid diethylamide (LSD 25) and 5-hydroxytryptamine (serotonin) on the electrical activity of the brain of the conscious cat.
    BRADLEY PB; HANCE AJ
    J Physiol; 1956 May; 132(2):50-1P. PubMed ID: 13320431
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blockade of dextran-anuria in water deprived rats through the serotonin antagonists lysergic acid diethylamide and 1-methyl-lysergic acid butanolamide].
    Taborsky J
    Med Pharmacol Exp Int J Exp Med; 1967; 17(1):6-10. PubMed ID: 6072683
    [No Abstract]   [Full Text] [Related]  

  • 16. A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.
    Colpaert FC; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1982 Apr; 221(1):206-14. PubMed ID: 7062283
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of lysergic acid derivatives on 5-hydroxytryptamine excitation of brain stem neurones.
    Boakes RJ; Bradley PB; Briggs I; Dray A
    Br J Pharmacol; 1970 Feb; 38(2):453P-454P. PubMed ID: 5417881
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistent effects of repeated injections of D-lysergic acid diethylamide on rat brain 5-hydroxytryptamine and 5-hydroxyindoleacetic acid levels.
    Peters DA; Tang S
    Biochem Pharmacol; 1977 Jun; 26(11):1085-6. PubMed ID: 880261
    [No Abstract]   [Full Text] [Related]  

  • 19. Actions of derivatives of lysergic acid on the heart of Venus mercenaria.
    WRIGHT AM; MOCRHEAD M; WELSH JH
    Br J Pharmacol Chemother; 1962 Apr; 18(2):440-50. PubMed ID: 14008412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of effect of antagonists on serotonin-induced inhibition in rat hippocampus.
    Penington NJ; Reiffenstein RJ
    Can J Physiol Pharmacol; 1986 Nov; 64(11):1413-8. PubMed ID: 3791042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.